Skip to main content
Premium Trial:

Request an Annual Quote

Layoffs at 23andMe

23andMe has laid off about 100 employees from its consumer business, as GenomeWeb reports. It says that this represents about 14 percent of the overall 23andMe workforce.

CNBC traces this move to a decline in sales, and CEO Anne Wojcicki tells it that she was surprised by the turn in the market but notes privacy concerns could be a factor as could fears of a wider economic downturn. "This has been slow and painful for us," Wojcicki tells CNBC.

The Verge reports that other genetic testing companies have also noted a shrinking market. Illumina reported last year, it says, that there had been a decline in the direct-to-consumer genetic testing space and that Veritas Genomics recently paused its US operations and laid off staff. GenomeWeb also notes that Helix had layoffs and shifted its focus to population genomics partnerships.

Privacy has also been an increasing concern for the field, as people have become worried about how their data could be used, CNBC adds. 

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.